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SUMMARY: 3TS-F442A adipocytes incubated in the presence of growth hormone 
(GH) showed a transient stimulation of the incorporation of [14C]glucose 
into cellular lipids, or production of 14C02 in the first 4 hr. ~y 48 hr, 
a significant suppression of glucose metabolism was evident, and persisted for 
7 days. Both effects resulted from direct in vitro addition of GH to 3T3 
adipocytes. This system therefore provides -t-he first appropriate cellular 
model for examination of both the characteristic acute stimulatory and delayed 
suppressive actions of GH on glucose metabolism. ©z9~4 Acad~iceress, Inc. 
Previous studies on the actions of growth hormone (GH) in vivo provide 
evidence for its wide variety of metabolic effects. These include stimulation 
of lipolysis (i), exacerbation of diabetes (2,3), and suppression of 
sensitivity to insulin (2,4). These effects usually require prolonged 
elevation of GH, for they are delayed in onset. Attempts to study them in 
vitro in sensitive target tissues (e.g. adipose tissue from hypophysectomized 
rats) have been difficult, since the delayed effects of GH do not have 
straightforward in vitro correlates. For example, the lipolytic action of GH 
has been observed in vitro primarily as a potentiation of other lipolytic 
stimuli such as dexamethasone or theophylline (5,6). GH does not appear to 
alter the effectiveness of insulin when the hormones are added in vitro (7,8), 
and its ability to suppress glucose metabolism requires at least 1-2 days in 
vitro (7,8), hence is limited by survival of tissue or cell preparations. 
However, in vitro studies have revealed that GH also has acute and transient 
"insulin-like" properties (1,9), whose physiological importance is unclear. 
ABBREVIATIONS. hGH : human growth hormone, DMEM = Dulbecco's Modified Eagle's 
Medium, BSA : bovine ser.,m albumin. 
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At present, little is known about cellular mechanisms by which GH exerts any 
of its effects. This is in part due to the lack of a simple and reliable in 
vitro system for analysis of such mechanisms, particularly with respect to the 
long-term effects of GH which are of physiological and clinical significance 
(e.g. insulin antagonism, diabetogenicity). 
The present study describes for the first time effects of human pituitary 
GH on glucose oxidation and incorporation of glucose into lipid in 3T3-F442A 
adipocytes. This cell line, of embryonic mouse origin, accumulates lipid 
after the preadipocytes reach confluence, and differentiate to cells with 
characteristics of adipocytes (i0,Ii). Differentiation of the preadlpocytes 
has been shown to he dependent on GH (12,13), although GH is not required to 
maintain the cells in the differentiated state. We have used the converted 
3T3 adipocytes to demonstrate first, the characteristic transient stimulation 
of glucose utilization (9). Second, we demonstrate that GH suppresses glucose 
utilization in a highly reproducible fashion in 24-48 hr. This suppression, 
which is relevant to the diabetogenic action of GH, lasts for 7 days. Thus, 
the cultured 3T3 adipocytes provide a useful system for examination of 
cellular aspects of GH action, and for evaluating biological activity of GH in 
clinical and physiological contexts. 
MATERIALS AND METHODS 
Materials: 3T3-F442A cells were generously provided by Dr. H. Green. All 
media and sera were obtained from Grand Island Biological Co. Human GH (A 
type monomer, lot KI205B3A) was kindly provided by Dr. J. L. Kostyo. 
Uniformly labelled [14C]-D-glucose was purchased from New England Nuclear. 
Dexamethasone was a gift of W. Henckler of Merck & Co. and crystalline porcine 
insulin (lot 615-144-2A) was kindly provided by R. Chance of Eli Lilly, Inc. 
Methylisobutylxanthine and BSA (fatty acid free) were purchased from Sigma. 
All other materials were of the highest grade available. 
Cell culture: Cells were plated at a density of 200/cm 2 in i00 mm Coming 
dishes and grown to confluence in DMEM containing 4.5 g/L glucose and 10% calf 
serum at 37°C in an atmosphere of 10% C02-90% air. Conversion to adipocytes 
was initiated by incubation in DMEM containing final concentrations of 
dexamethasone (0.25 uM), methylisobutylxanthine (0.5 mM), insulin (2 ug/ml), 
and 10% fetal calf serum. After 48 h, cells were maintained in DMEM 
containing 8 or 10% fetal calf serum and were used 5-8 days later. Conversion 
was evaluated by phase contrast microscopy and was estimated at 70-85%. The 
medium was replaced with DMEM (i g/L glucose) containing 1% BSA, 22-24 hr 
prior to experiments 
Lipld Accumulation. Monolayers of converted cells were incubated in DMEM 
containing I gTL glucose, 1% BSA, [14C]glucose (0.i uCi/ml), and hormones, 
for varying periods of time at 37°C. Incorporation of [14C]glucose was 
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stopped by aspirating the medium and immediately replacing it with 5 ml Dole's 
reagent (40 parts isopropyl alcohol, i0 parts heptane, 1 part i N H2S04). 
Cells were scraped off the dishes, and llpids were extracted by the method of 
Dole and Meinertz (14). The liplds were weighed, and incorporated 
radioactivity was counted by liquid scintillation spectrometry. Data are 
expressed as dpm/mg lipid. 
Glucose oxidation and incorporation into li~id. Suspensions of converted 
adipocytes were prepared using Joklik's medium in the presence of EDTA, as 
described by Deutsch and Rosen (15). They were resuspended to a final 
concentration of 2.5 x 105 cells/ml in Krebs Ringer bicarbonate buffer 
containing i mM glucose, 1% BSA, [14C]glucose (0.i uCi/ml), and hormones as 
indicated, and were incubated at 37°C for i or 4 hr, as indicated, under an 
atmosphere of 95% 02-5% CO 2. Each condition was tested in quadruplicate. 
Evolved 14C02 was collected and the amount of radioactivity incorporated 
into cellular llpids was determined, as described previously (16). Data are 
expressed as dpm/mg lipid x hr. Statistical comparisons were by Student's 
t-test. 
RESULTS 
Table 1 illustrates that continuous exposure to GH produces both an early 
stlmulatory and subsequent inhibitory effect on the incorporation of glucose 
into lipid in converted 3T3 adlpocytes. In this experiment, a significant 
stimulation of lipid synthesis by GH was evident at 1 and 4 hr, but had 
subsided by 22 hr, despite the continued presence of GH. This is consistent 
with the previously described transient nature of "insulin-like" responses to 
GH observed in adipose tissue. When the incubation time was extended, 48 hr 
of continued exposure to GH resulted in a sustained suppression of lipid 
accumulation, as shown in Fig. i. The suppression persisted for at least 7 
days, since the incorporation of label into lipid in the cells incubated 
without GH continued to increase, while that in cells incubated with GH was 
markedly attenuated. The viability of the cells, estimated by trypan blue 
Table i. Effects of various periods of incubation with GH on lipid 
accumulation in 3T3-F442A adipocytes 
[14C] Glucose incorporation 
(dpm/mg lipid) 
1 hr 4 hr 22 hr 
C 353 + 13" 678 + 40 3552 + 473 
GH 472 + 14 808 + 18 2522 + 358 
p 0.001 0.05 ns 
*mean~ standard error, n=4. Human GH was present at 1 ug/ml 
239 








I I I I I I I 
I 2 3 4 5 6 7 
DAYS 
Fisure i. Lipid accumulation in 3T3-F442A adipocytes incubated in the absence 
(O) or presence ( [] ) of GH. Day 0 represents the initiation of incubation 
with [14C]glueose, in the absence (control) or presence of hGH (i ug/ml). 
Each point represents the mean + standard error of quadruplicate observations. 
exclusion (16-18% non-vlable), was not appreciably changed during prolonged 
incubation. The transient nature of the stimulatory response to GH observed 
in the 3T3 adipocytes is specific to GH and characteristic of its effects on 
adipose tissue (9). The chronic (7 day) suppression of lipid synthesis by GH 
in the 3T3 adipocytes has not been demonstrated before. 
The time course of the effect of GH on the rate of glucose metabolism was 
evaluated over a 24 hr period. In the experiment shown in Table 2, adipocytes 
were incubated with the indicated hormones for a total of i, 4 or 24 hr. For 
the i and 4 hr incubations, suspensions of cells were incubated with 
[14C]glucose, and glucose utilization was measured, for the total period of 
exposure to the hormones. For the 24 hr incubation, monolayers of adipocytes 
were exposed to hormone continuously for 20 hr, and then were suspended in the 
presence of the same hormones and [14C]glucose for measurements of glucose 
utilization during the final 4 hr of incubation. In cells exposed to GH for 
the first i or 4 hr, the rate of incorporation of glucose into lipid or of 
glucose oxidation was significantly greater than control. After a total of 24 
hr of incubation with GH, however, both indicators of glucose utilization were 
significantly lower than control in GH-treated cells. In separate experiments 
(not shown), the rate of glucose metabolism tested after 48 hr also remained 
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Table 2. Effect of GH or insulin on rates of glucose utilization in 3T3 
adipocytes 
Treatment Duration of total incubation (hours) 
i 4 24 
A. [14C]02 Production (dpm/mg lipid x hr) 
Control 1179 + 18 1265 + 45 7382 + 252 
GH 1773 + 33 a 1905 + 48 a 2857 + 534 a 
Insulin 2359 + 16 a 4249 + 72 a 16420 + 305 a 
B. [14C] Glucose incorporation (dpm/mg lipid x hr) 
Control 316 + 19 181 + 8 457 + 13 
GH 559 + 71 b 446 + 76 b 203 + 13 a 
Insulin 897 + 49 a 1158 + 6 a 3220 + 97 a 
*mean + standard error, n=4. Human GH was present at 0.5 ug/ml, insulin at 
100 uU/ml, for the total period indicated. The [14C]glucose was also 
present, and glucose oxidation and incorporation into lipid were measured, 
during the first hr for the 1 hr interval, during the first 4 hr for the 4 hr 
incubation period. For the 24 hr incubation, monolayers of cells were exposed 
to the indicated hormones for 20 hr, then were suspended and incubated with 
the same hormones and [14C]glucose, and glucose utilization was measured for 
the final 4 hr. Data are normalized as dpm/mg lipid x hr for comparative 
purposes, a p<0.001 vs control, b p<0.02 vs control. 
lower in GH-treated cells as compared to control cells. Note that glucose 
oxidation and lipid synthesis in cells incubated with insulin were greater 
than control values throughout the 24 hr incubation. This clearly 
distinguishes the transient stimulation by hGH from the continually 
stimulatory effect of insulin. 
DISCUSSION 
This study provides the first in vitro evidence of a direct suppression of 
glucose metabolism by GH in 3T3 adipocytes. This is likely to be a component 
of the diabetogenic action of GH. While the induction of diabetes by GH is 
evident in vivo in some species (2), a suitable in vitro indicator of this 
effect of GH has not been available. In the converted 3T3 adipocytes, the 
suppression of glucose oxidation or incorporation into lipid was significant 
in 24-48 h in every experiment (n=5), and was sustained for 7 days. Thus, 
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these studies also establish that 3T3 adipocytes are a reliable in vitro 
system for examination of cellular aspects of GH action. It is noteworthy 
that an acute stimulation of glucose metabolism by GH was also evident in 
these cells. This insulin-like action was transient, in contrast to the 
continual stimulation caused by insulin. In comparison to studies in adipose 
tissue from hypophysectomized rats, the time course of the acute response to 
GH is somewhat delayed (17). The reasons for this difference remain to be 
established. It should also be recognized that lipolytic properties 
attributable to GH may contribute to the overall changes in lipid accumulation 
observed in these experiments. 
These studies do not address the issue of whether GH alters sensitivity to 
insulin in the 3T3 adipocytes. Such changes could be an important component 
of the diabetogenic action of GH in intact animals. However, in a study by 
Maloff et al. (7) using rat adipose tissue explants in culture, 48 hr exposure 
to GH also suppressed basal glucose transport, but did not alter insulin 
binding or the ability of insulin to stimulate transport. Similar findings 
were reported by Nyberg and Smith (8), using cultured human adipose tissue. 
The 3T3 adipocyte system is considerably simpler than either of these 
preparations. It does not require exposure of cells to collagenase, which 
interferes with metabolic effects of GH (16). In the present study, 
qualitatively similar responses to GH were obtained whether cells were studied 
in monolayer or in suspension. Hence, the suspension procedure used does not 
appear to interfere with the biological responses to GH, as does collagenase 
digestion. 
While direct addition of GH to the incubation medium clearly elicits the 
stimulation and subsequent suppression of glucose metabolism, it is not yet 
known what events transpire between initial exposure to GH and these 
responses. GH binds to the 3T3-F442A cells rapidly and specifically under the 
conditions of these experiments (Schwartz, unpublished observations). Nixon 
and Green made similar observations (18), and reported that binding was 
comparable in preconverted and converted cells. It is of interest that our 
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preliminary data indicate that the preconverted cells do not exhibit metabolic 
responses to GH. Although purified rat somatomedin affected rat adipose 
tissue comparably to insulin rather than to GH (19), the possibility remains 
that some intracellular mediator may be generated in the 3T3 adipocytes in 
response to GH. 
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